These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 14676135)

  • 1. Apoptosis inhibitors for heart disease.
    Webster KA; Bishopric NH
    Circulation; 2003 Dec; 108(24):2954-6. PubMed ID: 14676135
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice.
    Hayakawa Y; Chandra M; Miao W; Shirani J; Brown JH; Dorn GW; Armstrong RC; Kitsis RN
    Circulation; 2003 Dec; 108(24):3036-41. PubMed ID: 14638549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological growth synergizes with pathological genes in experimental cardiomyopathy.
    Syed F; Odley A; Hahn HS; Brunskill EW; Lynch RA; Marreez Y; Sanbe A; Robbins J; Dorn GW
    Circ Res; 2004 Dec; 95(12):1200-6. PubMed ID: 15539635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Fas-ten" your seat belt: anti-apoptotic treatment in heart failure takes off.
    von Harsdorf R
    Circ Res; 2004 Sep; 95(6):554-6. PubMed ID: 15375021
    [No Abstract]   [Full Text] [Related]  

  • 5. G-proteins in growth and apoptosis: lessons from the heart.
    Adams JW; Brown JH
    Oncogene; 2001 Mar; 20(13):1626-34. PubMed ID: 11313910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans.
    Frey UH; Lieb W; Erdmann J; Savidou D; Heusch G; Leineweber K; Jakob H; Hense HW; Löwel H; Brockmeyer NH; Schunkert H; Siffert W
    Eur Heart J; 2008 Apr; 29(7):888-97. PubMed ID: 18326504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44).
    Edes IF; Tóth A; Csányi G; Lomnicka M; Chłopicki S; Edes I; Papp Z
    J Mol Cell Cardiol; 2008 Sep; 45(3):363-72. PubMed ID: 18674539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury.
    Mocanu MM; Baxter GF; Yellon DM
    Br J Pharmacol; 2000 May; 130(2):197-200. PubMed ID: 10807653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of endothelin in the development of cardiac hypertrophy].
    Hasegawa H; Komuro I
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():617-21. PubMed ID: 15506460
    [No Abstract]   [Full Text] [Related]  

  • 11. Galphaq and its Aktions.
    Harris DM; Eckhart AD; Koch WJ
    J Mol Cell Cardiol; 2006 May; 40(5):589-92. PubMed ID: 16630627
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic factors in cardiac hypertrophy.
    Dorn GW; Hahn HS
    Ann N Y Acad Sci; 2004 May; 1015():225-37. PubMed ID: 15201163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection.
    D'Souza M; Garza MA; Xie M; Weinstock J; Xiang Q; Robinson P
    J Parasitol; 2007 Oct; 93(5):1121-7. PubMed ID: 18163347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype.
    Mende U; Semsarian C; Martins DC; Kagen A; Duffy C; Schoen FJ; Neer EJ
    J Mol Cell Cardiol; 2001 Aug; 33(8):1477-91. PubMed ID: 11448136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible caspase inhibitors: tools for studying apoptosis.
    Wu JC; Fritz LC
    Methods; 1999 Apr; 17(4):320-8. PubMed ID: 10196103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart disease. How to subdue a swelling heart.
    Marx J
    Science; 2003 Jun; 300(5625):1492-6. PubMed ID: 12791957
    [No Abstract]   [Full Text] [Related]  

  • 17. Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload.
    Sano M; Schneider MD
    Circulation; 2002 Jan; 105(1):8-10. PubMed ID: 11772868
    [No Abstract]   [Full Text] [Related]  

  • 18. Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease.
    Balsam LB; Mokhtari GK; Jones S; Peterson S; Hoyt EG; Kofidis T; Tanaka M; Cooke DT; Robbins RC
    J Heart Lung Transplant; 2005 Jul; 24(7):827-32. PubMed ID: 15982609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matter of life and death: cardiac myocyte apoptosis and regeneration.
    Nadal-Ginard B; Kajstura J; Anversa P; Leri A
    J Clin Invest; 2003 May; 111(10):1457-9. PubMed ID: 12750394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.